Krementz ET, Muchmore JH, Carter RD, Sutherland CM: Regional chemotherapy for melanoma of the limbs. Contrib Oncol. 1988, 29: 247-260.
Google Scholar
Pace M: Optimization of the vascular isolation in isolated regional perfusion of the limbs. Reg Cancer Treat. 1990, 3: 90-97.
Google Scholar
Noorda EM, Takkenberg B, Vrouenraets BC, Nieweg OE, van Geel BN, Eggermont AM, Hart GA, Kroon BB: Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma. Ann Surg Oncol. 2004, 11 (5): 491-499. 10.1245/ASO.2004.04.032.
Article
Google Scholar
Reintgen DS, Cox C, Slingluff CL, Seigler HF: Recurrent malignant melanoma: the identification of prognostic factors to predict survival. Ann Plast Surg. 1992, 28 (1): 45-49. 10.1097/00000637-199201000-00013.
Article
CAS
Google Scholar
Cavaliere R, Ciocatto EC, Giovanella BC, Heidelberger C, Johnson RO, Margottini M, Mondovi B, Moricca G, Rossi-Fanelli A: Selective heat sensitivity of cancer cells. Cancer. 1967, 20: 1351-1381. 10.1002/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO;2-#.
Article
CAS
Google Scholar
Stehlin JS: Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg Gynecol Obstet. 1969, 129: 305-308.
Google Scholar
Bhuyan BK: Kinetics of cell kill by hyperthermia. Cancer Res. 1979, 39: 2277-2284.
CAS
Google Scholar
Hahn GM, Shiu EC: Effect of pH and elevated temperature on the cytotoxicity of some chemotherapeutic agents on Chinese hamster cells in vitro. Cancer Res. 1983, 43: 5789-5791.
CAS
Google Scholar
Oleson JR, Calderwood SK, Coughlin CT, Dewhirst MW, Gerweck LE, Gibbs FA, et al: Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol. 1988, 11 (3): 368-380. 10.1097/00000421-198806000-00013.
Article
CAS
Google Scholar
Zaffaroni N, Villa R, Daidone MG, Vaglini M, Santinami M, Silvestrini R: Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanoma. Int J Cell Cloning. 1989, 7: 385-394.
Article
CAS
Google Scholar
Skene AI, Bulman AS, Williams TR, Meirion TJ, Westburg G: Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb. Br J Surg. 1990, 77: 765-767. 10.1002/bjs.1800770716.
Article
CAS
Google Scholar
Vrouenraets BC, Veld GJ, Nieweg OE, van Slooten GW, van Dongen JA, Kroon BBR: Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan. Eur J Surg Oncol. 1999, 25 (Suppl 5): 503-508. 10.1053/ejso.1999.0686.
Article
CAS
Google Scholar
Storm FK, Morton DL: Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity. Am J Surg. 1985, 150: 32-35. 10.1016/0002-9610(85)90006-6.
Article
CAS
Google Scholar
Stehlin JS, Giovanella BC, De Ipolyi PD, Muenz LR, Anderson RF: Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet. 1975, 140 (3): 339-348.
CAS
Google Scholar
Ghussen F, Kruger I, Groth W, Stutzer H: The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma. Cancer. 1988, 61: 654-659. 10.1002/1097-0142(19880215)61:4<654::AID-CNCR2820610406>3.0.CO;2-V.
Article
CAS
Google Scholar
Pace M, Galli A, Sussi S, Bellacci A: True hyperthermia in isolated regional perfusion for the treatment of limb melanoma. Reg Cancer Treat. 1991, 4: 35-
Google Scholar
Hafström L, Rudenstam CM, Blomquist E, Ingvar C, Jönsson PE, Lagerlöf B, Lindholm C, Ringborg U, Westman G, Ostrup L: Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group. J Clin Oncol. 1991, 9 (12): 2091-2094.
Google Scholar
Meyer T, Gohl J, Haas C, Hohenberger W: Hyperthermic isolated limb perfusion-23 years experience and improvement of results by modification of technique. Onkologie. 1998, 21: 198-202. 10.1159/000026815.
Article
Google Scholar
Wieberdink J, Benckhuijsen C, Braat RP, van Slooten EA, Olthuis GAA: Dosimetry in isolated perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clinic Oncol. 1982, 18: 905-910. 10.1016/0277-5379(82)90235-8.
Article
CAS
Google Scholar
Balch C: Cutaneous Melanoma. 1998, ST. Luis, MO: Quality Medical Publishing, 3
Google Scholar
Pace M, Filomena A, Galli A: Thermal induction and temperature control in the hiperthermic antiblastic regional perfusion with extra-corporeal circulation. In Consensus on Hyperthermia for the 1990s. Clinical Practice in Cancer Treatment. Edited by: Bicher HI et al. 1990, New York:. Plenum Press, 399-403.
Google Scholar
Pace M, Millanta L, Bellacci A, Galli A, Lazzerini S: Heat admistration temperature monitoring and control in hyperthermic antiblastic perfusion of the limbs. Reg Cancer Treat. 1993, 4: 207-212.
Google Scholar
Pace M, Millanta L, Galli A, Bellacci A: Closely controlled, highly reproducible and uniform temperature distribution in hyperthermal isolated limb perfusion. Reg Cancer Treat. 1994, 2: 94-98.
Google Scholar
Pace M, Millanta L, Polignano M, Gattai R, Macera Mascitelli E: Optimal procedure for thermal delivery in hyperthermic/chemotherapeutic treatments in the isolated perfusion of the the limbs. J Exp Clin Cancer Res. 2005, 24 (1): 35-42.
CAS
Google Scholar
Gattai R, Macera Mascitelli M, Millanta L, Polignano M, Bini M, Ignesti A, et al: Computerization and electronic integration in the optimization of biomedical system for the hyperthermic antiblastic perfusion in extracorporeal circulation. By-Pass. 2003, 15 (Suppl 1): 2043-2046.
Google Scholar
Pace M, Millanta L, Gattai R, Matteini M, Vaggelli L, Macera Mascitelli E, Bechi P: Key factors for best control of the systemic leakage during hyperthermic isolated limb perfusion (HILP) in ECC. A critical synthesis of our experience. J Exp Clin Cancer Res. 2007, 26: 433-442.
CAS
Google Scholar
Leakage monitoring: Beromun ILP Procedure Guide. 1999, Boehringer Ingelheim Pharma KG, 11-13.
Google Scholar
Kroon BBR, Klase JM, van Geel AN, Eggermont AMM: Application of hyperthermia in regional isolated perfusion for melanoma of the limbs. Reg Cancer Treat. 1992, 4: 223-226.
Google Scholar
Evaluation of efficacy of adjuvant hyperthermic isolation perfusion in stage I high risk (thickness ≥ 1.5 mm) cutaneous melanoma of lower limbs. WHO Melanoma Programme 17.1991.
Pace M, Millanta L, Bellacci M, Galli A, Lazzerini S: Heat administration temperature monitoring and control in hyperthermic – antibalstic perfusion of the limbs. Reg Cancer Treat. 1992, 4: 207-212.
Google Scholar
Koops HS, Vaglini M, Suciu S, Kroon BB, Thompson JF, Göhl J, Eggermont AM, Di Filippo F, Krementz ET, Ruiter D, Lejeune FJ: Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 1 the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. J Clin Oncol. 1998, 16 (9): 2906-2912.
CAS
Google Scholar
Miller AB, Hoogstratem B, Staquet M: Reporting results of cancer treatment. Cancer. 1981, 47: 207-214. 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6.
Article
CAS
Google Scholar
Noorda EM, Vrouenraets BC, Nieweg OE, Klaase JM, Zee van der J, Kroon BBR: Long-term results of a double perfusion schedule using high dose hyperthermia and melphalan sequentially in extensive melanoma of the lower limb. Melanoma Research. 2003, 13: 395-399. 10.1097/00008390-200308000-00009.
Article
CAS
Google Scholar
Pace M, Galli A, Bellacci A: True hyperthermia plus double melphalan bolus in the isolated perfusion for stage III lower limb melanoma. A pilot study Reg Cancer Treat. 1996, 9: 1-7.
Google Scholar
Pace M, Galli A, Bellacci A: Local and systemic toxicity in 'borderline true' hyperthermic isolated perfusion for lower limb melanoma. Melanoma Research. 1995, 5: 371-376. 10.1097/00008390-199510000-00011.
Article
CAS
Google Scholar
Lazzerini S, Millanta L, Olmi R, Pace M: An analysis of heat supply and temperature distribution in isolated hyperthermic perfusion of the limbs. Phys Med. 1991, 7: 135-143.
Google Scholar
Knorr C, Meyer T, Janssen T, Goehl J, Hohenberger W: Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients. Eur J Surg Oncol. 2006, 32: 224-227. 10.1016/j.ejso.2005.09.007.
Article
CAS
Google Scholar